Provided by Tiger Trade Technology Pte. Ltd.

Hillhouse Capital Related

459.937
+0.1450.03%
Number of Gainers:21
Number of Losers:27
Number of Flat:3
PE:- -
High:462.725
Open:459.044
Low:457.047
Close:459.793
Volume:114.00M
Turnover:2.63B
Market Cap:2.91T
Float Cap:2.02T

Loading ...

Haidilao Co-founder's HK$2.75 Billion Share Sale Triggers 12% Stock Plunge, Raising Questions About Insider Confidence

Deep News
·
Sep 09

Founder Family's Unexpected $350 Million Share Sale Sends Hotpot Giant's Stock into a Tailspin

Deep News
·
Sep 09

Haidilao Hits over 4-1/2-Year Low on Report Key Shareholder Unloading Shares

Reuters
·
Sep 09

CLSA Highlights Return of Stock-Specific Drivers in China's Innovative Drug Sector, Sees Macro Swings as Entry Points

Stock News
·
Sep 09

Haidilao shares plummet over 12% to a two-year low as founder's spouse reportedly sells at a discount

Deep News
·
Sep 09

Haidilao Shareholders Price Block Trade at 10.62 HKD Per Share, 6.7% Below Tuesday's Close

Deep News
·
Sep 09

Haidilao's Stock Plunges on Reports of Major Shareholder Share Sale

Deep News
·
Sep 09

Hygeia Healthcare Earns Outperform Rating with HK$14.69 Price Target from Huachuang Securities

Stock News
·
Sep 09

HK-Listed HBM Climbs on Initiating Next Phase of Asthma Drug Study

Reuters
·
Sep 09

Hong Kong Stock Market Movers: HBM Holdings-B (02142) Climbs Over 4% in Morning Session After Positive Asthma Trial Results and Stock Connect Inclusion

Stock News
·
Sep 09

Jinhai Med Tech Surges Over 21% Intraday as Minimally Invasive Business Jumps More Than Threefold in H1

Deep News
·
Sep 09

HAIDILAO (06862) Plunges Over 10% in Morning Trade as Pre-Market Block Deal Sparks Share Sale Speculation

Stock News
·
Sep 09

MicroPort Artemis Dream Intracranial Stent Enters China NMPA Innovative Device Review Program

Reuters
·
Sep 09

HBM Holdings' Asthma Therapy Shows Promising Phase II Results and Moves to Phase III

Stock News
·
Sep 08

HBM Says Partner Windward Bio Starts Phase 3 Asthma Trial of Twice-Yearly TSLP Antibody Hbm9378/win378

Reuters
·
Sep 08

Hbm9378/Win378, an Ultra-Long-Acting Antibody Targeting Tslp, Achieves Positive Phase 2 Results in Asthma and Initiates Phase 3 Study

THOMSON REUTERS
·
Sep 08

5万治疗费背后,“毛孩子”的晚年谁来守护?宠物抗癌险应运而生

Deep News
·
Sep 08

BAIRONG AI-W (06608) Announces Share Buyback on September 8, Spending HK$77,200

Stock News
·
Sep 08

Bairong Files HKEX Next-Day Disclosure Return on Share Buyback at HKD 4.98

Reuters
·
Sep 08

HYGEIA HEALTH Spends HK$1.55 Million on Share Buyback on September 8

Stock News
·
Sep 08